Bluejay Diagnostics Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
BJDX Nasdaq 3841 https://bluejaydx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bluejay Diagnostics Inc

Bluejay Reports FDA Agrees to Consider its Plan to Pursue a De Novo Regulatory Pathway for the Symphony IL-6 Test - Jun 9th, 2022 11:30 am
As Bluejay Diagnostics, Inc. (NASDAQ:BJDX) gains 41%, insiders who bought last year may be wishing they had bet higher - May 5th, 2022 3:21 pm
Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results - Apr 20th, 2022 8:10 pm
Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance - Mar 28th, 2022 11:00 am
Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer - Mar 24th, 2022 11:00 am
Companies Like Bluejay Diagnostics (NASDAQ:BJDX) Are In A Position To Invest In Growth - Mar 17th, 2022 10:53 am
Bluejay Diagnostics, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update - Mar 10th, 2022 12:00 pm
Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package for the Symphony IL-6 Test is with the FDA - Jan 31st, 2022 12:00 pm
Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care - Jan 13th, 2022 4:29 pm
10 Low-Float Penny Stocks for Steel-Gutted Investors - Jan 11th, 2022 9:19 pm
Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor - Jan 5th, 2022 1:15 pm
Bluejay Diagnostics, Inc. Reports Third Quarter 2021 Financial Results - Dec 16th, 2021 2:11 pm
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday - Dec 7th, 2021 12:25 pm
Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6 Million Initial Public Offering - Nov 10th, 2021 1:15 pm